Stephen J. Tulipano

2021 - Stoke Therapeutics

In 2021, Stephen J. Tulipano earned a total compensation of $3.1M as Chief Financial Officer at Stoke Therapeutics.

Compensation breakdown

Bonus$8,320
Non-Equity Incentive Plan$183,040
Option Awards$2,484,499
Salary$416,000
Other$9,707
Total$3,101,566

Tulipano received $2.5M in option awards, accounting for 80% of the total pay in 2021.

Tulipano also received $8.3K in bonus, $183K in non-equity incentive plan, $416K in salary and $9.7K in other compensation.

Rankings

In 2021, Stephen J. Tulipano's compensation ranked 4,303rd out of 12,415 executives tracked by ExecPay. In other words, Tulipano earned more than 65.3% of executives.

ClassificationRankingPercentile
All
4,303
out of 12,415
65th
Division
Manufacturing
1,777
out of 5,505
68th
Major group
Chemicals And Allied Products
745
out of 2,375
69th
Industry group
Drugs
665
out of 2,096
68th
Industry
Pharmaceutical Preparations
472
out of 1,546
70th
Source: SEC filing on April 27, 2023.

Tulipano's colleagues

We found two more compensation records of executives who worked with Stephen J. Tulipano at Stoke Therapeutics in 2021.

2021

Edward Kaye

Stoke Therapeutics

Chief Executive Officer

2021

Barry Ticho

Stoke Therapeutics

Chief Medical Officer

News

In-depth

You may also like